Sign in
CompletedPhase 1

A PHASE 1, RANDOMIZED, DOUBLE-BLIND, PARALLEL AND PLACEBO-CONTROLLED SINGLE AND MULTIPLE ASCENDING DOSE TRIAL INVESTIGATING SAFETY, TOLERABILITY AND PHARMACOKINETICS OF LIB-01 IN HEALTHY PARTICIPANTS

Key facts

Who runs it
Dicot AB
Where
Sweden1 site in 1 countryChoose a country to see its sites
Status
Completed
Phase
Phase 1
People taking part
72 people enrolled
Started
25 Aug 2023
Ended
4 Apr 2024
Type of study
Interventional
Record updated
5 October 2023

Who can take part

Age
18 years and older
Sex
Men only
Healthy volunteers
Can take part

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Record updated
5 October 2023